Study With [225Ac]Ac-FL-020 in mCRPC Participants

NCT06492122 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

DRUG: [225Ac]Ac-FL-020
DRUG: Blood samples for PK
DRUG: [111In]In-FL-020
PROCEDURE: Blood and urine samples collection
PROCEDURE: SPECT/CT images

Sponsor

Full-Life Technologies GmbH